XENON
Live / Applied — Ex parte appeal pending (as of 05 Mar 2026)
What this means for you
Not registered yet, but its 21 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98978167
- Mark type
- Word mark
- Filed
- 21 May 2024
- Attorney of record
- CHRISTINA M. LICURSI
Goods and services
- Class 005 — Pharmaceuticals: A house mark for pharmaceutical preparations for the treatment of neurological disorders, excluding products containing xenon gas, other gases, and products delivered through inhalation therapy
Owner
- XENON PHARMACEUTICALS INC., Burnaby, CA
Prior registrations
Prosecution history
- 06 May 2026 — AMENDMENT TO USE PROCESSING COMPLETE
- 05 Mar 2026 — USE AMENDMENT FILED
- 06 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 May 2026 — DIVISIONAL PROCESSING COMPLETE
- 05 Mar 2026 — DIVISIONAL REQUEST RECEIVED
- 12 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Mar 2026 — ASSIGNED TO LIE
- 05 Mar 2026 — TEAS AMENDMENT OF USE RECEIVED
- 05 Mar 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 05 Mar 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 05 Mar 2026 — EX PARTE APPEAL-INSTITUTED
- 05 Mar 2026 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 05 Mar 2026 — EXPARTE APPEAL RECEIVED AT TTAB
- 07 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED